Recent in vitro data have also revealed that mTOR can directly interact with AR in the nucleus of prostate cancer cells to promote metabolic rewiring, and high levels of nuclear mTOR correlate with poor prognosis in patients with prostate cancer [293]. This evidence concerns the gene AR and prostate carcinoma.